Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;42(5):776-792.
doi: 10.1002/jimd.12152. Epub 2019 Aug 5.

Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A review

Affiliations
Review

Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A review

Lakshminarayan R Ranganath et al. J Inherit Metab Dis. 2019 Sep.

Abstract

Ochronosis is the process in alkaptonuria (AKU) that causes all the debilitating morbidity. The process involves selective deposition of homogentisic acid (HGA)-derived pigment in tissues altering the properties of these tissues, leading to their failure. Some tissues like cartilage are more easily affected by ochronosis while others such as the liver and brain are unaffected for reasons that are still not understood. In vitro and mouse models of ochronosis have confirmed the dose relationships between HGA and ochronosis and also their modulation by p-hydroxyphenylpyruvate dioxygenase inhibition. Ochronosis cannot be fully reversed and is a key factor in influencing treatment decisions. Earlier detection of ochronosis preferably by noninvasive means is desirable. A cause-effect relationship between HGA and ochronosis is discussed. The similarity in AKU and familial hypercholesterolaemia is explored and lessons learnt. More research is needed to more fully understand the crucial nature of ochronosis.

Keywords: alkaptonuria; homogentisic acid; in vitro; natural history; ochronosis; pigment; severity.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Knox WE. Sir Archibald Garrod's inborn errors of metabolism. IV. Pentosuria. Am J Hum Genet. 1958;10:385-397.
    1. Galdston M, Steele JM, Dobriner K. Alcaptonuria and ochronosis; with a report of three patients and metabolic studies in two. Am J Med. 1952;13:432-452.
    1. Garrod AE. The incidence of alkaptonuria: a study in chemical individuality. Lancet. 1902;2:1616-1620. https://doi.org/10.1016/S0140-6736(01)41972-6.
    1. O'Brien WM, La Du BN, Bunim JJ. Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy-review of world literature (1584-1962). Am J Med. 1963;34:813-838. https://doi.org/10.1385/1-59259-763-7.
    1. Bhattar P, Zawar V, Godse K, et al. Exogenous ochronosis. Indian J Dermatol. 2015;60:537-542. https://doi.org/10.4103/0019-5154.169122.

Substances

LinkOut - more resources